The impact of primary patella resurfacing on health-related quality of life outcomes and return to sport in total knee arthroplasty (TKA).


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 27 02 2023
accepted: 22 05 2023
medline: 5 10 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Primary patella resurfacing (PPR) in primary total knee arthroplasty (TKA) is a topic without clear clinical evidence. Using Patient Reported Outcome Measurements (PROM), previous work found TKA patients without PPR to have more pain postoperatively, but little is known whether this may impede patients from returning to their usual leisure sport. This observational study aimed at evaluating the treatment effect of PPR, with PROMs and return to sport (RTS). 156 primary TKA patients were retrospectively included from August 2019 to November 2020, from a single hospital in Germany. PROMs were measured with the Western Ontario McMaster University Osteoarthritis Index (WOMAC) and the EuroQoL Visual Analog Scale (EQ-VAS), preoperatively and 1 year postoperatively. Leisure sport with three levels of intensity (never, sometimes, regular) were requested. The treatment effect of PPR was evaluated with a difference-in-difference (DiD) approach, with several confounders. Descriptively, the mean WOMAC total score and the mean WOMAC pain score were postoperatively better with PPR, ( - 4.8 points,  - 1.1 points), then without PPR. The mean improvements of the WOMAC total score were better with PPR ( - 7.8 points). Mean improvements for the WOMAC pain score were also better with PPR ( - 1.2 points). Mean EQ-VAS were postoperatively similar, and the mean improvements were better with PPR (3.4 points). Rate of RTS was 93% for patients with PPR and 95% for patients without PPR. The DiD revealed minor differences in PROMs and RTS, not to result in statistically significant treatment effects. There was no treatment effect for TKA with PPR, regarding PROMs and RTS, and descriptive differences were below published thresholds for clinical relevance. Rate of RTS was high for all patients, regardless of PPR. For the two endpoint categories, there was no measurable advantage of TKA with PPR over TKA without PPR.

Identifiants

pubmed: 37289223
doi: 10.1007/s00402-023-04930-x
pii: 10.1007/s00402-023-04930-x
pmc: PMC10248965
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6731-6740

Subventions

Organisme : German Federal Ministry of Education and Research
ID : 01GY1603A

Informations de copyright

© 2023. The Author(s).

Références

Arthroscopy. 2022 Jun;38(6):1888-1889
pubmed: 35660183
JAMA. 2014 Dec 10;312(22):2401-2
pubmed: 25490331
Knee Surg Sports Traumatol Arthrosc. 2022 Oct;30(10):3304-3310
pubmed: 35211774
Bone Joint Res. 2022 Sep;11(9):619-628
pubmed: 36047008
Knee Surg Sports Traumatol Arthrosc. 2022 Mar;30(3):1025-1038
pubmed: 33661323
Bone Joint J. 2014 Nov;96-B(11 Supple A):84-6
pubmed: 25381415
J Arthroplasty. 2020 Aug;35(8):2274-2285.e1
pubmed: 32389409
J Orthop Surg Res. 2021 Apr 15;16(1):264
pubmed: 33858458
J Am Acad Orthop Surg. 2010 Feb;18(2):72-82
pubmed: 20118324
Health Serv Res. 2021 Oct;56(5):932-941
pubmed: 33978956
J Arthroplasty. 2018 Jun;33(6):1962-1971.e3
pubmed: 29398258
Acta Orthop. 2017 Oct;88(5):484-489
pubmed: 28640672
Arch Bone Jt Surg. 2018 Mar;6(2):124-129
pubmed: 29600265
J Knee Surg. 2021 Sep;34(11):1212-1219
pubmed: 32268405
Prev Med. 2021 Jul;148:106520
pubmed: 33744329
Health Technol Assess. 2014 Mar;18(19):1-235, vii-viii
pubmed: 24679222
Clin Orthop Relat Res. 2018 Oct;476(10):2005-2014
pubmed: 30179956
Arch Orthop Trauma Surg. 2022 Nov;142(11):3427-3436
pubmed: 34564735
J Orthop Surg Res. 2021 Jan 25;16(1):83
pubmed: 33494774
J Arthroplasty. 2018 Nov;33(11):3412-3415
pubmed: 30122432
Rev Bras Ortop (Sao Paulo). 2021 Mar 31;56(6):741-746
pubmed: 34900102
J Bone Joint Surg Am. 2018 Sep 19;100(18):1539-1548
pubmed: 30234618

Auteurs

Caroline Schatz (C)

Ludwig-Maximilians-Universität München, LMU Munich School of Management, Institute for Health Economics and Health Care Management, Ludwigstr. 28, 80539, Munich, Germany. schatz@lmu.de.
Helmholtz Zentrum München, Institute for Health Economics and Health Care Management, Munich, Germany. schatz@lmu.de.
Environmental Health Center at Helmholtz Munich, Munich, Germany. schatz@lmu.de.

Werner Plötz (W)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.
Klinikum Rechts Der Isar, Technical University Munich, Munich, Germany.
Orthopedic Praxis Munich-Nymphenburg, Munich, Germany.

Johannes Beckmann (J)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.

Reiner Leidl (R)

Ludwig-Maximilians-Universität München, LMU Munich School of Management, Institute for Health Economics and Health Care Management, Ludwigstr. 28, 80539, Munich, Germany.
Helmholtz Zentrum München, Institute for Health Economics and Health Care Management, Munich, Germany.

Peter Buschner (P)

Krankenhaus Barmherzige Brüder München, Akademisches Lehrkrankenhaus der Technischen Universität München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH